Market News & Trends
Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta & Other Facilities
The Lubrizol Corporation recently announced its LifeSciences business continues to invest in its key capabilities through a variety of planned expansions. During this latest phase,…
Acasti Pharma & CordenPharma Announce Large-Scale Production of CaPre With Continuous Manufacturing
Acasti Pharma Inc. recently announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate,…
Acasti Pharma & CordenPharma Announce Large-Scale Production of CaPre With Continuous Manufacturing
Acasti Pharma Inc. recently announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate,…
Acasti Pharma & CordenPharma Announce Large-Scale Production of CaPre With Continuous Manufacturing
Acasti Pharma Inc. recently announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate,…
Acasti Pharma & CordenPharma Announce Large-Scale Production of CaPre With Continuous Manufacturing
Acasti Pharma Inc. recently announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate,…
Acasti Pharma & CordenPharma Announce Large-Scale Production of CaPre With Continuous Manufacturing
Acasti Pharma Inc. recently announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate,…
Vetter & Microdermics Enter Into Strategic Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal…
Vetter & Microdermics Enter Into Strategic Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal…
Vetter & Microdermics Enter Into Strategic Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal…
Vetter & Microdermics Enter Into Strategic Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal…
Vetter & Microdermics Enter Into Strategic Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal…
Debiopharm Acquires Phase II Asset From ImmunoGen
Debiopharm International SA, part of Debiopharm Group, recently announced that it has acquired ImmunoGen’s IMGN529/DEBIO 1562, a clinical-stage anti-CD37 ADC for the treatment of patients…
OrphoMed Secures $39 Million
OrphoMed, Inc. recently announced the completion of a $39-million Series A financing. The round was led by New Enterprise Associates (NEA), and co-led by existing…
Teneobio & Poseida Announce License Agreement for the Use of UniDab in CAR T-Cell Therapy
Teneobio, Inc. and Poseida Therapeutics, Inc. recently announced they have entered a commercial license agreement for the use of Teneobio’s UniDabs, single-domain, human heavy chain…
Kamada Presents Updated Data From Phase 2 Clinical Trial for Inhaled Therapy
Kamada Ltd. recently announced that a poster comprising updated data from the company’s US Phase 2 clinical trial of its proprietary inhaled Alpha-1 Antitrypsin (AAT)…
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
Inovio Pharmaceuticals, Inc. recently announced that its HIV vaccine, PENNVAX-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated…
Attune Pharmaceuticals Announces Positive Data
Attune Pharmaceuticals recently announced positive results from preclinical safety studies evaluating ATN-249, a novel orally administered plasma kallikrein inhibitor for the treatment of Hereditary Angioedema…
Hovione Announces Start of Phase 1 Clinical Trial
Hovione recently announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline…
Hovione Announces Start of Phase 1 Clinical Trial
Hovione recently announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline…
PCT Now a Global CDMO as Part of Hitachi Chemical
On May 18, 2017, PCT announced that Hitachi Chemical Co. America, Ltd. (Hitachi Chemical’s consolidated subsidiary) completed its purchase of the 80.1% remaining membership interest…
